发明授权
- 专利标题： Methods of treating breast cancer with anthracycline therapy
- 专利标题（中）： 用蒽环类药物治疗乳腺癌的方法
-
申请号： US13421367申请日： 2012-03-15
-
公开(公告)号： US09066963B2公开(公告)日： 2015-06-30
- 发明人: Charles M. Perou , Matthew J. Ellis , Philip S. Bernard , Torsten O. Nielsen
- 申请人： Charles M. Perou , Matthew J. Ellis , Philip S. Bernard , Torsten O. Nielsen
- 申请人地址： US NC Chapel Hill US MO St. Louis US UT Salt Lake City CA Vancouver, British Columbia
- 专利权人： The University of North Carolina at Chapel Hill,Washington University,University of Utah Research Foundation,British Columbia Cancer Agency Branch
- 当前专利权人： The University of North Carolina at Chapel Hill,Washington University,University of Utah Research Foundation,British Columbia Cancer Agency Branch
- 当前专利权人地址： US NC Chapel Hill US MO St. Louis US UT Salt Lake City CA Vancouver, British Columbia
- 代理机构： Cooley LLP
- 代理商 Ivor R. Elrifi; Matthew Pavao
- 主分类号： A61K31/704
- IPC分类号： A61K31/704 ; A61K31/7042 ; A61K45/06 ; A61K31/513 ; A61K31/675 ; C12Q1/68
摘要：
The application describes methods for screening subjects with breast cancer to determine if the breast cancer will be responsive to a breast cancer therapy including an anthracycline. The application also describes methods for treating subjects with breast cancer by screening them for the likelihood of the effectiveness of treating the cancer with a therapy including anthracycline and administering the therapy in subjects when it is found that anthracycline is likely to be effective.